“WNS’s approach to blending AI and Human Intelligence in its productized services stands out in today’s market. By delivering tailored, outcome-based solutions and fostering hands-on client collaboration, it's achieving impressive gains in efficiency and setting a new standard for value-driven partnerships. With continued investment in GenAI expansion and seamless tech integration, WNS is poised to lead the way in the AADA landscape."

— Ashish Chaturvedi, Practice Leader, HFS Research

WNS’ proprietary IPs, including SKENSE (AI / ML-led data processing platform), Malkom (intelligent automation platform for shipment lifecycle) and PRECIZON (pharma competitive intelligence platform), exemplify the company’s commitment to combining cutting-edge tech and human intelligence to provide clients with analytical and automation solutions.

To download the report, click here

Download Report

Join the conversation